chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Activities of daily living impaired, Hypotonia, Muscle tightness, Myalgia
Clinical narrative: For 2 days, pt experience moderate intense muscle tightness and aching and a sense of limps feeling limp.  This interfered with her ability to play sports.
Age: 74.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Herpes zoster, Injection site pain
Clinical narrative: Pt contacted Merck first to report adverse effects.  Merck faxed notification to agency and nurse called to follow up with pt.  Pt had reported to Merck blister-type rash on arms, back of legs and trunk - did not seek treatment.  Also stated that "entire family came down with symptoms of chicken pox after receiving the injection."  At time of nurse follow up, pt's blisters had dried up, no new blisters noted, but still some pain at injection site.  (Nurse called pt on 5/21/09 - 23 days after injection).  Progress note from 4/28/09 (when immunization was ordered for pt) states that pt's 38 yo son had recently been diagnosed with shingles.
Age: 74.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Pain in extremity, Pruritus, Rash, Skin lesion
Clinical narrative: Pt contacted Merck first to report adverse effects.  Merck faxed notification to agency and nurse called to follow up with pt.  Pt had reported to Merck blister-type rash on arms, back of legs and trunk - did not seek treatment.  Also stated that "entire family came down with symptoms of chicken pox after receiving the injection."  At time of nurse follow up, pt's blisters had dried up, no new blisters noted, but still some pain at injection site.  (Nurse called pt on 5/21/09 - 23 days after injection).  Progress note from 4/28/09 (when immunization was ordered for pt) states that pt's 38 yo son had recently been diagnosed with shingles.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Sinusitis, Swelling face, Urticaria
Clinical narrative: Chronic Hives...They were first noticed around mid January 2009.  We first saw our pediatrician who thought it was viral.  Then we went to see an Allergist who noticed she had a sinus infection.   She has been on prednisone for facial swelling, Xyzal, Cingular, Benedryl, Zyrtec and 3 different antibiotics.  She has had her blood drawn 4 times to see if there is anything serious like lupus or thyroid.  Everything is fine.  She has just had sinus surgery for her chronic sinus infection.  We were hoping this was the case but her hives had been much worse since the surgery on June 24, 2009.  My instincts have always told me it was a reaction to Gardasil.  I have been hoping it was the sinus infection but it looks like it is not.
Age: 36.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal discomfort, Lymphadenopathy, Nausea
Clinical narrative: Next day, pt called to report GI sxs: nausea, upset stomach. Day later, she reported swollen lymph node in armpit of left arm where she got vaccine
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Body temperature increased, Condition aggravated, Diarrhoea, Hypersomnia, Infantile spitting up
Clinical narrative: TEMP 99.7 TO 100.8 FOR 2 DAYS, INCREASE ON SLEEP, INCREASE SPIT UP, RUNNY DIARRHEA/STOOL
Sex: F
Vaccine: TTOX
Symptoms: Erythema, Injection site pruritus, Mass, Oedema peripheral, Pain
Clinical narrative: right arm started getting red over 24 hrs with lump forming underneath skin.  By 36 hrs, arm swollen to size of tennis ball with red color & warmth at touch. Took 50mg benadryl for it.  Also on cleocin 300 mg qid for infected laceration, ibuprofen 600mg q 6 hrs pain, lortab 7.5 prn pain.  Two days later from shot time slightly improved but still red swollen warm.  Dr in urgent care said need to watch close for abcess forming.  The next day same s/s & then itching began at site as well. Added hydrocortisone cream around outside of injection site. This is helping with redness. Lump remains approx slightly bigger than the size sliced golf ball.
Sex: F
Vaccine: TTOX
Symptoms: Skin warm
Clinical narrative: right arm started getting red over 24 hrs with lump forming underneath skin.  By 36 hrs, arm swollen to size of tennis ball with red color & warmth at touch. Took 50mg benadryl for it.  Also on cleocin 300 mg qid for infected laceration, ibuprofen 600mg q 6 hrs pain, lortab 7.5 prn pain.  Two days later from shot time slightly improved but still red swollen warm.  Dr in urgent care said need to watch close for abcess forming.  The next day same s/s & then itching began at site as well. Added hydrocortisone cream around outside of injection site. This is helping with redness. Lump remains approx slightly bigger than the size sliced golf ball.
Age: 1.08
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, HEPA, MMR, PNC, VARCEL
Symptoms: Anorexia, Body temperature increased, Diarrhoea, Dyskinesia, Electroencephalogram
Clinical narrative: rash at injection site, R leg "hundred-ish tiny bumps with white pink tips"; later rash appeared on face and neck; T max 102 F; diarrhea. the night of 6/25/09 parent reports pt experienced body jerking/twitching/mouth movements; poor appetite. parent tx with tylenol, ibuprofen. patient referred for MRI and EEG
Age: 1.08
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, HEPA, MMR, PNC, VARCEL
Symptoms: Injection site erythema, Injection site rash, Muscle twitching, Nuclear magnetic resonance imaging, Rash
Clinical narrative: rash at injection site, R leg "hundred-ish tiny bumps with white pink tips"; later rash appeared on face and neck; T max 102 F; diarrhea. the night of 6/25/09 parent reports pt experienced body jerking/twitching/mouth movements; poor appetite. parent tx with tylenol, ibuprofen. patient referred for MRI and EEG
Age: 1.08
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL, HEPA, MMR, PNC, VARCEL
Symptoms: Convulsion, Electroencephalogram, Nuclear magnetic resonance imaging, Pyrexia, Rash
Clinical narrative: rash at injection site, R leg "hundred-ish tiny bumps with white pink tips"; later rash appeared on face and neck; T max 102 F; diarrhea. the night of 6/25/09 parent reports pt experienced body jerking/twitching/mouth movements; poor appetite. parent tx with tylenol, ibuprofen. patient referred for MRI and EEG
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP, HPV4, TDAP
Symptoms: Behcet's syndrome, Blood test, Computerised tomogram, Headache, Herpes virus infection
Clinical narrative: First event 4 days after vaccine (2nd) dose...vaginal lesions, nausea,vomitting, headache -E.R visit diagnosed with herpes, all subsequent tests negative - 6/7/09 headache, fever, lesions: mouth and vaginal, aspetic meningitis, hospitilized for 5 days- diagnosed with Behcets disease  7/16/09 Medical records received DOS 7/25/07 to 7/08/2009. Assessment: Meningitis, viral unspecified. Behcet's Syndrome. Patient presents with papular lesion on outer vaginal opening. Vulva - White papular lesions. Vulvovaginitis. Increasing painful multiple ulcers vaginal area, purulant discharge, pain with urination. Genital herpes. Wart right hand. Vulvovaginitis. Hospitalized for viral meningitis. Rash: torso and arms -hyperpigmented patches, legs - flesh colored nontender papules. Consultation note: Oral-genital ulcers with papular rash and meningeal symptoms.  7/16/09 Hospital discharge summary DOS 6/14/09 to 6/17/09. Assessment: Behcets Patient presents with 3 days of severe frontal headache. 2 oral ulcers on tongue and 4 genital ulcers. Intermittant raised rash on torso and extremities. Nausea and vomiting. Not taking adequate PO.
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP, HPV4, TDAP
Symptoms: Lumbar puncture, Meningitis aseptic, Nausea, Nuclear magnetic resonance imaging, Oral disorder
Clinical narrative: First event 4 days after vaccine (2nd) dose...vaginal lesions, nausea,vomitting, headache -E.R visit diagnosed with herpes, all subsequent tests negative - 6/7/09 headache, fever, lesions: mouth and vaginal, aspetic meningitis, hospitilized for 5 days- diagnosed with Behcets disease  7/16/09 Medical records received DOS 7/25/07 to 7/08/2009. Assessment: Meningitis, viral unspecified. Behcet's Syndrome. Patient presents with papular lesion on outer vaginal opening. Vulva - White papular lesions. Vulvovaginitis. Increasing painful multiple ulcers vaginal area, purulant discharge, pain with urination. Genital herpes. Wart right hand. Vulvovaginitis. Hospitalized for viral meningitis. Rash: torso and arms -hyperpigmented patches, legs - flesh colored nontender papules. Consultation note: Oral-genital ulcers with papular rash and meningeal symptoms.  7/16/09 Hospital discharge summary DOS 6/14/09 to 6/17/09. Assessment: Behcets Patient presents with 3 days of severe frontal headache. 2 oral ulcers on tongue and 4 genital ulcers. Intermittant raised rash on torso and extremities. Nausea and vomiting. Not taking adequate PO.
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP, HPV4, TDAP
Symptoms: Pyrexia, Vaginal lesion, Vomiting
Clinical narrative: First event 4 days after vaccine (2nd) dose...vaginal lesions, nausea,vomitting, headache -E.R visit diagnosed with herpes, all subsequent tests negative - 6/7/09 headache, fever, lesions: mouth and vaginal, aspetic meningitis, hospitilized for 5 days- diagnosed with Behcets disease  7/16/09 Medical records received DOS 7/25/07 to 7/08/2009. Assessment: Meningitis, viral unspecified. Behcet's Syndrome. Patient presents with papular lesion on outer vaginal opening. Vulva - White papular lesions. Vulvovaginitis. Increasing painful multiple ulcers vaginal area, purulant discharge, pain with urination. Genital herpes. Wart right hand. Vulvovaginitis. Hospitalized for viral meningitis. Rash: torso and arms -hyperpigmented patches, legs - flesh colored nontender papules. Consultation note: Oral-genital ulcers with papular rash and meningeal symptoms.  7/16/09 Hospital discharge summary DOS 6/14/09 to 6/17/09. Assessment: Behcets Patient presents with 3 days of severe frontal headache. 2 oral ulcers on tongue and 4 genital ulcers. Intermittant raised rash on torso and extremities. Nausea and vomiting. Not taking adequate PO.
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP, HPV4, TDAP
Symptoms: Blood test normal, Culture negative, Headache, Pyrexia, Vaginal discharge
Clinical narrative: First event 4 days after vaccine (2nd) dose...vaginal lesions, nausea,vomitting, headache -E.R visit diagnosed with herpes, all subsequent tests negative - 6/7/09 headache, fever, lesions: mouth and vaginal, aspetic meningitis, hospitilized for 5 days- diagnosed with Behcets disease  7/16/09 Medical records received DOS 7/25/07 to 7/08/2009. Assessment: Meningitis, viral unspecified. Behcet's Syndrome. Patient presents with papular lesion on outer vaginal opening. Vulva - White papular lesions. Vulvovaginitis. Increasing painful multiple ulcers vaginal area, purulant discharge, pain with urination. Genital herpes. Wart right hand. Vulvovaginitis. Hospitalized for viral meningitis. Rash: torso and arms -hyperpigmented patches, legs - flesh colored nontender papules. Consultation note: Oral-genital ulcers with papular rash and meningeal symptoms.  7/16/09 Hospital discharge summary DOS 6/14/09 to 6/17/09. Assessment: Behcets Patient presents with 3 days of severe frontal headache. 2 oral ulcers on tongue and 4 genital ulcers. Intermittant raised rash on torso and extremities. Nausea and vomiting. Not taking adequate PO.
Age: 21.0
Sex: F
Vaccine: HPV4, TDAP, HPV4, TDAP
Symptoms: Vaginal lesion
Clinical narrative: First event 4 days after vaccine (2nd) dose...vaginal lesions, nausea,vomitting, headache -E.R visit diagnosed with herpes, all subsequent tests negative - 6/7/09 headache, fever, lesions: mouth and vaginal, aspetic meningitis, hospitilized for 5 days- diagnosed with Behcets disease  7/16/09 Medical records received DOS 7/25/07 to 7/08/2009. Assessment: Meningitis, viral unspecified. Behcet's Syndrome. Patient presents with papular lesion on outer vaginal opening. Vulva - White papular lesions. Vulvovaginitis. Increasing painful multiple ulcers vaginal area, purulant discharge, pain with urination. Genital herpes. Wart right hand. Vulvovaginitis. Hospitalized for viral meningitis. Rash: torso and arms -hyperpigmented patches, legs - flesh colored nontender papules. Consultation note: Oral-genital ulcers with papular rash and meningeal symptoms.  7/16/09 Hospital discharge summary DOS 6/14/09 to 6/17/09. Assessment: Behcets Patient presents with 3 days of severe frontal headache. 2 oral ulcers on tongue and 4 genital ulcers. Intermittant raised rash on torso and extremities. Nausea and vomiting. Not taking adequate PO.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Arthralgia, C-reactive protein increased, Henoch-Schonlein purpura, Joint swelling, Pyrexia
Clinical narrative: Received DTaP, MMR, IPV, Varivax on 6-17-2009.  Had had brief joint pain and mild rash approx 5 days prior and only faint pinpoint macular rash on ventral forearms at well visit on 6-17-2009.  Developed Fever (102) and joint pain at the lower extremities on 6-18-2009 that worsened.  She was seen for ankle swelling and rash on 6-20-2009 in ED, labwork unremarkable except ESR 36. Subsequently admitted on 6-21-09 for Henoch Schoenlein Purpura.  She has recovered fully after 2 days in the hospital.  7/6/09 Hospital records received DOS 6/21/09 0/23/09. Assessment: Henoch-Schonlein purpura. Patient presented with joint pain, petechial purpuric rash buttocks, lower extremities and feet, swelling, and discomfort. Difficulty walking. Later worsening of symptoms, swelling on the lower back area with tenderness. Lesions raised and tender, angioedema back. Swelling of feet, ankles, knees.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Rash, Rash macular, Red blood cell sedimentation rate increased, White blood cell count increased
Clinical narrative: Received DTaP, MMR, IPV, Varivax on 6-17-2009.  Had had brief joint pain and mild rash approx 5 days prior and only faint pinpoint macular rash on ventral forearms at well visit on 6-17-2009.  Developed Fever (102) and joint pain at the lower extremities on 6-18-2009 that worsened.  She was seen for ankle swelling and rash on 6-20-2009 in ED, labwork unremarkable except ESR 36. Subsequently admitted on 6-21-09 for Henoch Schoenlein Purpura.  She has recovered fully after 2 days in the hospital.  7/6/09 Hospital records received DOS 6/21/09 0/23/09. Assessment: Henoch-Schonlein purpura. Patient presented with joint pain, petechial purpuric rash buttocks, lower extremities and feet, swelling, and discomfort. Difficulty walking. Later worsening of symptoms, swelling on the lower back area with tenderness. Lesions raised and tender, angioedema back. Swelling of feet, ankles, knees.
Age: 17.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Blood pressure decreased, Cold sweat, Dizziness, Nausea, Pallor
Clinical narrative: Patiet received Menactra, Gardisil, Adacel, and, and Havrix. She became pale and nauseated. Her skin was cool and clammy. Her head went down appearing as if she was faint, but she was able to hear and answer questions.  Spirits of ammonia applied. BP was 70/40. She was then placed in a supine position with legs elevated. Her symptoms then subsided and BP returned to 110/70. She stayed at the state health center for one hour accompanied by her mother who drove her home.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Oedema peripheral, Pain in extremity, Skin warm
Clinical narrative: ON 6/27/2009 CLIENT NOTICED THAT LEFT ARM WAS SORE AND WARM TO TOUCH ALSO RED AND SWOLLEN, INSTRUCTED TO TAKE BENADRYL AT BEDTIME AND APPLY COLD PACK TO SITE FOR COMFORT. PATIENT STATES THAT ARM WAS BETTER TODAY
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Headache, Nausea, Pain in extremity, Tremor
Clinical narrative: Severe aches in joints, especially injected arm. Began severe headache, nausea, vomiting.  Body was quivering, jaw quivering bad pretty bad. Did not go to emergency room, but one step away from it. Still have pain in elbow of injected arm (right).
Age: 45.0
Sex: F
Vaccine: TDAP
Symptoms: Trismus, Vomiting
Clinical narrative: Severe aches in joints, especially injected arm. Began severe headache, nausea, vomiting.  Body was quivering, jaw quivering bad pretty bad. Did not go to emergency room, but one step away from it. Still have pain in elbow of injected arm (right).
Age: 0.92
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Crying, Insomnia, Opisthotonus, Pyrexia, Restlessness
Clinical narrative: Uncontrollable crying, arching back and restless no sleeping, High fever
Age: 23.0
Sex: F
Vaccine: RAB
Symptoms: Headache, Urticaria
Clinical narrative: Client stated that she developed hives on both arms and had a headache approximately 1 hour after receiving the vaccine.  She called her doctor's office who advised that she take 25 mg benadryl.  Client stated the symptoms resolved.
Age: 1.0
Sex: M
Vaccine: HIBV
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: RED ITCHY BUMPS ON BADY NOW SPREADING
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Back pain, Herpes zoster, Pain in extremity, Rash
Clinical narrative: Patient received Zostavax vaccine on 6/17/09.  States symptoms of pain in upper thighs began on 6/19/09, pain then elevated to lower back.  Visited md 1x and er 3x, thought possible kidney stones, rash began on back 6/25/09 and pt at this time was diagnosed with shingles.  Patient believes she got shingles from the vaccine.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Computerised tomogram normal, Enema administration, Fatigue, Gait disturbance
Clinical narrative: Patient received Zostavax vaccine on 6/17/09.  States symptoms of pain in upper thighs began on 6/19/09, pain then elevated to lower back.  Visited md 1x and er 3x, thought possible kidney stones, rash began on back 6/25/09 and pt at this time was diagnosed with shingles.  Patient believes she got shingles from the vaccine.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Liver function test normal, Musculoskeletal pain, Pain in extremity, Rash
Clinical narrative: Patient received Zostavax vaccine on 6/17/09.  States symptoms of pain in upper thighs began on 6/19/09, pain then elevated to lower back.  Visited md 1x and er 3x, thought possible kidney stones, rash began on back 6/25/09 and pt at this time was diagnosed with shingles.  Patient believes she got shingles from the vaccine.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Renal function test normal, Renal pain, Tenderness
Clinical narrative: Patient received Zostavax vaccine on 6/17/09.  States symptoms of pain in upper thighs began on 6/19/09, pain then elevated to lower back.  Visited md 1x and er 3x, thought possible kidney stones, rash began on back 6/25/09 and pt at this time was diagnosed with shingles.  Patient believes she got shingles from the vaccine.
Age: 43.0
Sex: F
Vaccine: MMR
Symptoms: Activities of daily living impaired, Arthralgia, Body temperature increased, Cough, Gait disturbance
Clinical narrative: 2 days after vaccination temp. - sore throat, cough. This lasted 2 1/2 weeks. Then on the 30th of May I awoke to a painful left knee. This got worse over the course of the day. By days end knee swollen- painful to walk on. Next morning both knees ached, they felt as if they were going to explode. Couldn't knell down, or go down stairs, moved up to hips.. This lasted about a week, then moved to hands, elbows, and feet, (knees and hips felt better). Hand and fingers swelled, I could barely bend them, constant aching. They would also feel as tough they were going to sleep. No position made any difference. Swelling has gone and tingling, numbness and pain in finger persist. Over the last week it comes and goes. 6-24 it has moved back to left knee. Only joints its missed is shoulders. As of this time it is still ongoing.
Age: 43.0
Sex: F
Vaccine: MMR
Symptoms: Hypoaesthesia, Joint range of motion decreased, Joint swelling, Oedema peripheral, Oropharyngeal pain
Clinical narrative: 2 days after vaccination temp. - sore throat, cough. This lasted 2 1/2 weeks. Then on the 30th of May I awoke to a painful left knee. This got worse over the course of the day. By days end knee swollen- painful to walk on. Next morning both knees ached, they felt as if they were going to explode. Couldn't knell down, or go down stairs, moved up to hips.. This lasted about a week, then moved to hands, elbows, and feet, (knees and hips felt better). Hand and fingers swelled, I could barely bend them, constant aching. They would also feel as tough they were going to sleep. No position made any difference. Swelling has gone and tingling, numbness and pain in finger persist. Over the last week it comes and goes. 6-24 it has moved back to left knee. Only joints its missed is shoulders. As of this time it is still ongoing.
Age: 43.0
Sex: F
Vaccine: MMR
Symptoms: Paraesthesia
Clinical narrative: 2 days after vaccination temp. - sore throat, cough. This lasted 2 1/2 weeks. Then on the 30th of May I awoke to a painful left knee. This got worse over the course of the day. By days end knee swollen- painful to walk on. Next morning both knees ached, they felt as if they were going to explode. Couldn't knell down, or go down stairs, moved up to hips.. This lasted about a week, then moved to hands, elbows, and feet, (knees and hips felt better). Hand and fingers swelled, I could barely bend them, constant aching. They would also feel as tough they were going to sleep. No position made any difference. Swelling has gone and tingling, numbness and pain in finger persist. Over the last week it comes and goes. 6-24 it has moved back to left knee. Only joints its missed is shoulders. As of this time it is still ongoing.
Age: 62.0
Sex: F
Vaccine: MMR
Symptoms: Burning sensation, Hypoaesthesia, Limb discomfort, Oedema peripheral, Pain
Clinical narrative: 05-27-09 Right hand swollen, numb - its mainly in my pointer finger, middle finger & thumb now.  I've had my left arm go numb & hurt & ache & feel like its on fire.  A burning sensation.  Then it will go away.  But tries to come back - the numbness.  (cont. on back)
Age: 5.0
Sex: M
Vaccine: MNQ, TYP, YF
Symptoms: Joint swelling, Oedema peripheral, Pyrexia, Urticaria
Clinical narrative: Reported  by mother:  5/8 Right arm swollen, followed by 7 days of hives, swollen knee joints, fever off and on, puffy feet".  Treated by hospital, and primary care with ZYRTEC and BENADRYL.  Seeing an allergist.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009:  15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007.  The children received a total of two doses (fully vaccinated).  Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness.  Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group.  This case refers to one child (for other children, please refer to reference cases MA2009-1708 to MA2009-1710 and MA2009-1712 to MA2009-1722).  Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Age: 17.0
Sex: M
Vaccine: HEPA, TDAP, TYP
Symptoms: Eye swelling, Pruritus, Rash, Skin discolouration
Clinical narrative: After taking 2 doses of VIVOTIF, deep pink colored rash to face, neck noted. Eyes swollen almost shut, c/o pruritic. Referred to PCP. Placed on steroids and anti histamines. Given permission by PCP to go abroad in 2 weeks.
Age: 10.0
Sex: F
Vaccine: HEPA, HPV4, VARCEL
Symptoms: Cold sweat, Immediate post-injection reaction, Pallor, Syncope, Unresponsive to stimuli
Clinical narrative: Client immediately suffered syncope episode after injection of GARDASIL. She was pale, clammy to touch and non-responsive for approx 1 minute. BP 77/54. Client awoke, was given sprite to drink and was observed for approx. 20 min. Client appeared fully recovered when she left with her mother. Followed-up 6/26/09, mother states client is well.
Age: 0.58
Sex: M
Vaccine: HEP, PNC, RV5
Symptoms: Dyspnoea, Pyrexia, Rash, Reaction to previous exposure to any vaccine, Respiratory disorder
Clinical narrative: 1st set (PENTACEL, HVB, PCV7, Rota) resulted in wheezing, SOB, irregular breathing, fever 104 degrees; seen in ER. 2nd set (PENTACEL, Rota) resulted in no symptoms. 3rd set (HBV, Rota, PCV) resulted in rash and swelling on face requiring BENADRIL PRN
Age: 0.58
Sex: M
Vaccine: HEP, PNC, RV5
Symptoms: Swelling face, Wheezing
Clinical narrative: 1st set (PENTACEL, HVB, PCV7, Rota) resulted in wheezing, SOB, irregular breathing, fever 104 degrees; seen in ER. 2nd set (PENTACEL, Rota) resulted in no symptoms. 3rd set (HBV, Rota, PCV) resulted in rash and swelling on face requiring BENADRIL PRN
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1709 to MA2009-1710 and MA2009-1712 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009:  15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007.  The children received a total of two doses (fully vaccinated).  Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness.  Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group.  This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708, MA2009-1710 and MA2009-1712 to MA2009-1722).  Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009. 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1709 and MA2009-1712 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?).  Request was sent on 22 JUN 2009, no follow-up information received.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Asthenia, Dizziness, Fatigue, Loss of consciousness
Clinical narrative: Approx. 5 minutes after receiving vaccines became dizzy.  Passed out.  Mom states it looked like he was having a seizure.  C/o weakness & being tired.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710 and MA2009-1713 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009:  15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007.  The children received a total of two doses (fully vaccinated).  Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness.  Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group.  This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 and MA2009-1714 to MA2009-1722).  Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1713 and MA2009-1715 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1714 and MA2009-1716 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Age: 32.0
Sex: M
Vaccine: MMR, TDAP
Symptoms: Ear discomfort, Lymphadenopathy, Pain
Clinical narrative: Pt reported swollen lymph nodes to neck and burning behind ear drums. 3 days after ADACEL/MMR II injection. Pt has been to ER (on 2/22/09 and wk another ER on 6/1/09). Pt also has pain at the base of his skull.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009. 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1715 and MA2009-1717 to MA2009-1722). Request was sent on 22 JUN 2009, no follow-up information received.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Electromyogram, Musculoskeletal pain, Nerve conduction studies, Neuralgia, Pain in extremity
Clinical narrative: Pt experienced arm pain and shoulder pain after injection - near inj site. Started days after inj; con't for ~ 2 months. It cleared but shortly thereafter pt has experienced nerve pain distally in the area - in hand laterally & forearm - non localizable on NOS - ulnar sensory neuropathy per neuro.
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Peripheral sensory neuropathy
Clinical narrative: Pt experienced arm pain and shoulder pain after injection - near inj site. Started days after inj; con't for ~ 2 months. It cleared but shortly thereafter pt has experienced nerve pain distally in the area - in hand laterally & forearm - non localizable on NOS - ulnar sensory neuropathy per neuro.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1716 and MA2009-1718 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009.  15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007.  The children received a total of two doses (fully vaccinated).  Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness.  Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group.  This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA20091717 and MA2009-1719 to MA2009-1722).  Laboratory-confirmed influenza was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: ANTH
Symptoms: Generalised erythema, Headache, Hypoaesthesia, Hypohidrosis, Insomnia
Clinical narrative: Headaches, irritation, lack of sweat doing exercise, insomnia, redness in all parts of body, numbness left lower foot, tingling sensation, weakness: in all extremities.
Sex: U
Vaccine: ANTH
Symptoms: Irritability, Muscular weakness, Paraesthesia
Clinical narrative: Headaches, irritation, lack of sweat doing exercise, insomnia, redness in all parts of body, numbness left lower foot, tingling sensation, weakness: in all extremities.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009:  15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007.  The children received a total of two doses (fully vaccinated).  Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness.  Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group.  This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1718 and MA2009-1720 to MA2009-1722).  Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009: 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1719 and MA2009-1721 to MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009. 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with unvaccinated group. This case refers to one child (for other children please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710, MA2009-1712 to MA2009-1720 and MA2009-1722). Laboratory-confirmed influenza illness was reported (date?). Request was sent on 22 JUN 2009, no follow-up information received.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Pyrexia, Rash pustular
Clinical narrative: Fevers, rash/pustules, RX with NSAIDS/observation for possible reaction
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Influenza serology positive
Clinical narrative: We received the following literature report on 15 JUN 2009. 15 children between 6 and 59 months of age were vaccinated for the first time with an influenza vaccine (batch no. and manufacturer unknown) at the start of each influenza season (defined from 01 NOV to 30 APR) from 1999-2000 through 2006/2007. The children received a total of two doses (fully vaccinated). Vaccine effectiveness among fully vaccinated children as compared with unvaccinated children was 86% (95% confidence interval: 29-97%) for medically attended, laboratory-confirmed influenza illness. Vaccine effectiveness for the partially vaccinated group was 73% (95% confidence interval: 3-93%) as compared with the unvaccinated group. This case refers to one child (for other children, please refer to reference cases MA2009-1692, MA2009-1708 to MA2009-1710 and MA2009-1712 to MA2009-1721. Laboratory-confirmed influenza illness was reported (date?).  Request was sent on 22 JUN 2009, no follow-up information received.
Age: 1.8
Sex: M
Vaccine: PNC, TDAP
Symptoms: Wrong drug administered
Clinical narrative: Tdap given instead of DTaP, no reaction to the Tdap.
Age: 0.4
Sex: M
Vaccine: IPV, PNC, RV5
Clinical narrative: Sudden Death.  8/12/09 Autopsy records received. CAUSE OF DEATH - SUDDEN UNEXPLAINED INFANT DEATH. Infant found prone with head between the mattress and netting wall of the porta-crib.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Swelling, Tenderness
Clinical narrative: Erythema, swelling, tenderness (all continued after 2 months)
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, VARCEL
Symptoms: Asthenopia, Back pain, Bartonella test positive, Eye inflammation, Eye operation
Clinical narrative: Pt c/o headache, the began c/o sensitivity to light. On 1/22/09 went to have eyes checked retinas inflamed. Went to ophthalmologist retinas being treated. Then pressure went up, and had surgery on R eye 6/23/09.  7/7/09 Consultant records received DOS 2/4/09 to 6/2/09. Assessment: Retinal vasculitis and vitritis, pars planitis, increased ocular pressure. Patient presents with flashes left eye, black lines. Headaches during day, eyes light sensitive. Floaters right eye. 8/24/09 Received Ophtho medical records of 6/9/09-8/18/09. FINAL DX: Pars planitis right eye; increased intraocular pressure. Patient tx w/diuretic & drops.  IOP remained high, developed severe HE..  Surgery of trabeculectomy w/antimetabolites, right eye done 6/23/09.  continued to have pain & blurred vision post operatively.  Developed heavy feeling in right eye, increased floaters in left eye & hazy vision.    6/30/09 Received PCP & vaccine records of 1/20/2009-2/4/09. Records reveal patient experienced back ache, cervicalgia, HA.  Received depo-provera & vaccines.  Referred to retina specialist on 2/3 but no office note. Follow-up: Pt has had 2 surgeries on her right eye. She will have 1 more next month. Her right eye droops, blocking her vision, sensitive to light.
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, VARCEL
Symptoms: Eyelid ptosis, Headache, Intraocular pressure increased, Intraocular pressure increased, Laboratory test
Clinical narrative: Pt c/o headache, the began c/o sensitivity to light. On 1/22/09 went to have eyes checked retinas inflamed. Went to ophthalmologist retinas being treated. Then pressure went up, and had surgery on R eye 6/23/09.  7/7/09 Consultant records received DOS 2/4/09 to 6/2/09. Assessment: Retinal vasculitis and vitritis, pars planitis, increased ocular pressure. Patient presents with flashes left eye, black lines. Headaches during day, eyes light sensitive. Floaters right eye. 8/24/09 Received Ophtho medical records of 6/9/09-8/18/09. FINAL DX: Pars planitis right eye; increased intraocular pressure. Patient tx w/diuretic & drops.  IOP remained high, developed severe HE..  Surgery of trabeculectomy w/antimetabolites, right eye done 6/23/09.  continued to have pain & blurred vision post operatively.  Developed heavy feeling in right eye, increased floaters in left eye & hazy vision.    6/30/09 Received PCP & vaccine records of 1/20/2009-2/4/09. Records reveal patient experienced back ache, cervicalgia, HA.  Received depo-provera & vaccines.  Referred to retina specialist on 2/3 but no office note. Follow-up: Pt has had 2 surgeries on her right eye. She will have 1 more next month. Her right eye droops, blocking her vision, sensitive to light.
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, VARCEL
Symptoms: Neck pain, Photophobia, Photopsia, Retinal exudates, Retinal haemorrhage
Clinical narrative: Pt c/o headache, the began c/o sensitivity to light. On 1/22/09 went to have eyes checked retinas inflamed. Went to ophthalmologist retinas being treated. Then pressure went up, and had surgery on R eye 6/23/09.  7/7/09 Consultant records received DOS 2/4/09 to 6/2/09. Assessment: Retinal vasculitis and vitritis, pars planitis, increased ocular pressure. Patient presents with flashes left eye, black lines. Headaches during day, eyes light sensitive. Floaters right eye. 8/24/09 Received Ophtho medical records of 6/9/09-8/18/09. FINAL DX: Pars planitis right eye; increased intraocular pressure. Patient tx w/diuretic & drops.  IOP remained high, developed severe HE..  Surgery of trabeculectomy w/antimetabolites, right eye done 6/23/09.  continued to have pain & blurred vision post operatively.  Developed heavy feeling in right eye, increased floaters in left eye & hazy vision.    6/30/09 Received PCP & vaccine records of 1/20/2009-2/4/09. Records reveal patient experienced back ache, cervicalgia, HA.  Received depo-provera & vaccines.  Referred to retina specialist on 2/3 but no office note. Follow-up: Pt has had 2 surgeries on her right eye. She will have 1 more next month. Her right eye droops, blocking her vision, sensitive to light.
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, VARCEL
Symptoms: Retinal vasculitis, Retinitis, Vision blurred
Clinical narrative: Pt c/o headache, the began c/o sensitivity to light. On 1/22/09 went to have eyes checked retinas inflamed. Went to ophthalmologist retinas being treated. Then pressure went up, and had surgery on R eye 6/23/09.  7/7/09 Consultant records received DOS 2/4/09 to 6/2/09. Assessment: Retinal vasculitis and vitritis, pars planitis, increased ocular pressure. Patient presents with flashes left eye, black lines. Headaches during day, eyes light sensitive. Floaters right eye. 8/24/09 Received Ophtho medical records of 6/9/09-8/18/09. FINAL DX: Pars planitis right eye; increased intraocular pressure. Patient tx w/diuretic & drops.  IOP remained high, developed severe HE..  Surgery of trabeculectomy w/antimetabolites, right eye done 6/23/09.  continued to have pain & blurred vision post operatively.  Developed heavy feeling in right eye, increased floaters in left eye & hazy vision.    6/30/09 Received PCP & vaccine records of 1/20/2009-2/4/09. Records reveal patient experienced back ache, cervicalgia, HA.  Received depo-provera & vaccines.  Referred to retina specialist on 2/3 but no office note. Follow-up: Pt has had 2 surgeries on her right eye. She will have 1 more next month. Her right eye droops, blocking her vision, sensitive to light.